AU2668699A - Methods and compositions for modulating leptin activity - Google Patents
Methods and compositions for modulating leptin activityInfo
- Publication number
- AU2668699A AU2668699A AU26686/99A AU2668699A AU2668699A AU 2668699 A AU2668699 A AU 2668699A AU 26686/99 A AU26686/99 A AU 26686/99A AU 2668699 A AU2668699 A AU 2668699A AU 2668699 A AU2668699 A AU 2668699A
- Authority
- AU
- Australia
- Prior art keywords
- compositions
- methods
- leptin activity
- modulating leptin
- modulating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4703—Inhibitors; Suppressors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Psychiatry (AREA)
- Biophysics (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Child & Adolescent Psychology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Diabetes (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US7432098P | 1998-02-11 | 1998-02-11 | |
US60074320 | 1998-02-11 | ||
US4427898A | 1998-03-19 | 1998-03-19 | |
US09044278 | 1998-03-19 | ||
PCT/US1999/002865 WO1999040946A2 (en) | 1998-02-11 | 1999-02-10 | Methods and compositions for modulating leptin activity |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2668699A true AU2668699A (en) | 1999-08-30 |
Family
ID=26721350
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU26686/99A Abandoned AU2668699A (en) | 1998-02-11 | 1999-02-10 | Methods and compositions for modulating leptin activity |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1053007A2 (en) |
JP (1) | JP2002506004A (en) |
AU (1) | AU2668699A (en) |
CA (1) | CA2320226A1 (en) |
WO (1) | WO1999040946A2 (en) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2335107C (en) | 1998-07-28 | 2010-01-19 | Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw | Leptin-mediated gene-induction |
US7078174B1 (en) | 1998-12-21 | 2006-07-18 | The Walter & Eliza Hall Institute Of Medical Research | Screening methods using SOCS box-containing peptides |
AU4651900A (en) * | 1999-04-20 | 2000-11-02 | Beth Israel Deaconess Medical Center | Methods and compositions for modulating ciliary neurotrophic factor activity |
SE9903953D0 (en) * | 1999-11-01 | 1999-11-01 | Sahltech Ab | New use of the jak-stat system |
AU4034601A (en) * | 2000-03-09 | 2001-09-17 | Inst Medical W & E Hall | Methods of regulating cytokine signalling |
AUPQ614700A0 (en) * | 2000-03-09 | 2000-03-30 | Walter And Eliza Hall Institute Of Medical Research, The | A method and agents useful for same |
AU2001281784B2 (en) | 2000-05-22 | 2005-09-15 | Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw | Receptor-based interaction trap |
ES2294048T3 (en) * | 2000-11-14 | 2008-04-01 | Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw. | FUNCTIONAL LEPTINE RECEIVER FRAGMENT. |
US7235629B2 (en) | 2000-11-14 | 2007-06-26 | Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw | Functional fragment of the leptin receptor |
AU2002950745A0 (en) * | 2002-08-13 | 2002-09-12 | The Walter And Eliza Hall Institute Of Medical Research | A method and agents useful for same |
US7423113B2 (en) | 2004-08-25 | 2008-09-09 | Vib Vzw | Leptin antagonist |
US8969291B2 (en) | 2004-10-08 | 2015-03-03 | Enzo Therapeutics, Inc. | Methods for decreasing leptin levels or activity for treating inflammation |
US7863240B2 (en) | 2004-10-08 | 2011-01-04 | Enzo Therapeutics, Inc. | Methods and uses of leptin in hepatocellular carcinoma |
US7575878B2 (en) | 2004-11-18 | 2009-08-18 | Vib Vzw | Methods of inhibiting leptin-induced signaling with fibronectin III domain antibodies |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0832284A1 (en) * | 1995-05-30 | 1998-04-01 | Smithkline Beecham Plc | Method for the detection of compounds that modulate the effects of the obese protein |
AU5926296A (en) * | 1996-05-21 | 1997-12-09 | President And Fellows Of Harvard College | Human cis protein |
KR20000053017A (en) * | 1996-11-01 | 2000-08-25 | 더 월터 앤드 엘리자 홀 인스티튜트 오브 메디컬 리서치 | Therapeutic and diagnostic agents capable of modulating cellular responsiveness to cytokines |
JP2001508312A (en) * | 1997-11-03 | 2001-06-26 | インサイト・ファーマスーティカルズ・インコーポレイテッド | Suppressor of cytokine signaling |
-
1999
- 1999-02-10 AU AU26686/99A patent/AU2668699A/en not_active Abandoned
- 1999-02-10 JP JP2000531197A patent/JP2002506004A/en active Pending
- 1999-02-10 WO PCT/US1999/002865 patent/WO1999040946A2/en not_active Application Discontinuation
- 1999-02-10 CA CA002320226A patent/CA2320226A1/en not_active Abandoned
- 1999-02-10 EP EP99906877A patent/EP1053007A2/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
EP1053007A2 (en) | 2000-11-22 |
CA2320226A1 (en) | 1999-08-19 |
WO1999040946A3 (en) | 1999-10-28 |
JP2002506004A (en) | 2002-02-26 |
WO1999040946A2 (en) | 1999-08-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU3387599A (en) | Methods and compositions for tissue regeneration | |
AU5230399A (en) | Pharmaceutical compositions and methods for managing scalp conditions | |
AU5898599A (en) | Methods and compositions for genomic modification | |
AU5081298A (en) | Surgical method and composition therefor | |
AU4407199A (en) | Copy protection method using broken modulation rules | |
AU1296099A (en) | Methods and compositions for treating dermatoses | |
AU2349399A (en) | R-lansoprazole compositions and methods | |
AU7260398A (en) | Method and composition for modulating amyloidosis | |
AU5565099A (en) | Pharmaceutical compositions and methods for use | |
AU5283199A (en) | Methods and composition for modulating flavonoid content | |
AU4215399A (en) | Dermatological compositions and methods | |
AU2668699A (en) | Methods and compositions for modulating leptin activity | |
AU7685798A (en) | Compositions and methods for preventing adhesion | |
AU4876397A (en) | Insecticidal compositions and methods | |
AU4981199A (en) | Compositions and methods for modulating sexual activity | |
AU5594398A (en) | Methods and compositions for preventing and treating bone loss | |
AU3200197A (en) | New composition and methods | |
AU5791698A (en) | Methods and compositions for preventing and treating bone loss | |
AUPO982097A0 (en) | Methods and compositions for use therein | |
AU2880699A (en) | Pharmaceutical compositions and methods for use | |
AU5243899A (en) | Methods and compositions for using moclobemide | |
AU8492598A (en) | Methods and compositions for tumor reduction | |
AU3900499A (en) | (+)-hydroxyrisperidone compositions and methods | |
AU1598600A (en) | Compositions and methods for modulating expression within smooth muscle cells | |
AU6149699A (en) | Pesticide composition and method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |